Trial · NCT05903716
The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris
NCT05903716, Unknown, Marmara University
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris. Trials, record NCT05903716. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT05903716
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Effects of Systemic Isotretinoin Treatment on Adrenal Steroid and Sex Hormones Level in Severe Acne Vulgaris
- NCT number
- NCT05903716
- Status
- Unknown
- Enrollment
- 40 participants, estimated
- Lead sponsor
- Marmara University
- Conditions
- Acne Vulgaris
- Interventions
- Hormone, Isotretinoin
- First posted
- 2023-06-15
- Last updated
- 2023-06-15
Source ClinicalTrials.gov
Registered outcomes57
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | FSH Level | Baseline (Before isotretinoin treatment) | Evaluation FSH levels in Severe Acne Vulgaris patient Before isotretinoin treatment |
| Primary | FSH Level | 3rd month of isotretinoin treatment | Evaluation FSH levels in after 3 month of isotretinoin treatment |
| Primary | LH Level | Baseline (Before isotretinoin treatment) | Evaluation LH levels in Severe Acne Vulgaris patient Before isotretinoin treatment |
| Primary | LH Level | 3rd month of isotretinoin treatment | Evaluation LH levels after 3 month of isotretinoin treatment |
| Primary | Prolactin Level | Baseline (Before isotretinoin treatment) | Evaluation Prolactin levels in Severe Acne Vulgaris patient Before isotretinoin treatment |
| Primary | Prolactin Level | 3rd month of isotretinoin treatment | Evaluation Prolactin levels after 3 month of isotretinoin treatment |
| Primary | Estrogen Level | Baseline (Before isotretinoin treatment) | Evaluation Estrogen levels in Severe Acne Vulgaris patient Before isotretinoin treatment |
| Primary | Estrogen Level | 3rd month of isotretinoin treatment | Evaluation Estrogen levels after 3 month of isotretinoin treatment |
| Primary | Testosterone Level | Baseline (Before isotretinoin treatment) | Evaluation Testosterone levels in Severe Acne Vulgaris patient Before isotretinoin treatment |
| Primary | Testosterone Level | 3rd month of isotretinoin treatment | Evaluation Testosterone levels after 3 month of isotretinoin treatment |
1 to 10 of 57Source ClinicalTrials.gov
See all 57 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT05903716
GET https://conductscience.org/api/trials/v1/NCT05903716/registered?page=2